Literature DB >> 28763729

An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium.

Li Dong1, Chunqing Lin1, Li Li2, Margaret Wang3, Jianfeng Cui1, Ruimei Feng1, Bin Liu1, Zeni Wu1, Jia Lian1, Guangdong Liao4, Wen Chen5, Youlin Qiao6.   

Abstract

BACKGROUNDS: Effective dry storage and transport media as an alternative to conventional liquid-based medium would facilitate the accessibility of women in the low-resource settings to human papillomavirus (HPV)- based cervical cancer screening.
OBJECTIVE: To evaluate analytical and clinical performance of indicating FTA™ Elute Cartridge (FTA card) for the detection of HPV16/18 and cervical precancerous lesions and cancer compared to dry swab and liquid medium. STUDY
DESIGN: Ninety patients with abnormal cytology and/or HPV infection were included for analysis. Three specimens of cervical exfoliated cells from each woman were randomly collected by FTA card, dry swab or liquid-based medium prior to colposcopy examination. The subsequent HPV DNA tests were performed on cobas 4800 HPV platform. RESULTS AND
CONCLUSIONS: High-risk HPV (hrHPV) positivity rate was 63.3%, 62.2% and 65.6% for samples collected by FTA card, dry swab and liquid medium, respectively. The overall agreements and kappa values for the detection of hrHPV, HPV 16 and HPV 18 between FTA card and liquid-based medium were 88.9% (κ=0.76), 97.8% (κ=0.94) and 100% (κ=1.0),respectively; between FTA card and dry swab were 92.1% (κ=0.83), 94.5% (κ=0.87) and 100% (κ=1.0), respectively. The performances of hrHPV tested by FTA card, dry swab, and liquid-based medium for detecting CIN2+ were comparable in terms of the sensitivity and specificity. The specificity of detection of CIN2+ by HPV16/18 increased by approximately 40% compared to hrHPV for any medium albeit at cost of a moderate loss of sensitivity. Dry medium might offer an alternative to conventional liquid-based medium in the HPV-based cervical cancer screening program especially in low-resource settings but still needs further evaluation.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Cervical cancer; Dry swab; FTA card; Human papillomavirus; Liquid medium

Mesh:

Substances:

Year:  2017        PMID: 28763729     DOI: 10.1016/j.jcv.2017.06.008

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  2 in total

1.  A systematic review of FTA cards® as a tool for viral RNA preservation in fieldwork: Are they safe and effective?

Authors:  Jaime A Cardona-Ospina; Manuel F Villalba-Miranda; Leidy A Palechor-Ocampo; Lida I Mancilla; Juan C Sepúlveda-Arias
Journal:  Prev Vet Med       Date:  2019-09-10       Impact factor: 2.670

2.  DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo.

Authors:  Mamy Ngole; Valerie Race; Gloire Mbayabo; Paul Lumbala; Cathy Songo; Prosper Tshilobo Lukusa; Koenraad Devriendt; Gert Matthijs; Aimé Lumaka
Journal:  J Clin Lab Anal       Date:  2022-04-11       Impact factor: 3.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.